Treatment of Peyronie's disease with oral colchicine: long-term results and predictive parameters of successful outcome

Kadioglu A., Tefekli A., Koksal T., Usta M., Erol H.

INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, vol.12, no.3, pp.169-175, 2000 (SCI-Expanded) identifier identifier identifier


As recent clinical and animal studies have indicated, colchicine, with its anti-fibrotic, anti-mitotic and anti-inflammatory activities, has suppressive effects in the pathogenesis of Peyronie's disease.